Photo from wikipedia
We evaluated whether the treatment history of low‐dose rituximab affected safety profiles, and humoral and cellular responses induced by severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine in… Click to show full abstract
We evaluated whether the treatment history of low‐dose rituximab affected safety profiles, and humoral and cellular responses induced by severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine in healthy controls and kidney transplant recipients.
Keywords:
safety;
dose rituximab;
kidney transplant;
transplant recipients;
low dose
Journal Title: International Journal of Urology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Urology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!